Lumida
/ITOS
⌘K
iTeos Therapeutics Inc

iTeos Therapeutics Inc

ITOS
$10.15USD+0.20%+0.02 today

MARKET CAP

448.7M

P/E (TTM)

FWD P/E

DAY RANGE

$10 – $10

52W RANGE

$5
$18
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024TREND
Sales, Adj.$344.8M$267.6M$12.6M$35.0M
YoY %-22.4%-95.3%+177.9%
P / Sales
EV / Sales
Gross Profit, Adj.$344.8M$267.6M$12.6M$35.0M
YoY %-22.4%-95.3%+177.9%
Margin %100.0%100.0%100.0%100.0%
EV / Gross Profit
EBITDA, Adj.$245.5M$127.1M$-150.2M$-158.3M
YoY %+649.2%-48.2%-218.2%-5.4%
Margin %71.2%47.5%-1192.6%-452.3%
EV / EBITDA
EBIT$244.9M$126.3M$-151.1M$-159.5M
YoY %+641.3%-48.4%-219.6%-5.6%
Margin %71.0%47.2%-1199.7%-455.8%
EV / EBIT
Net Income$214.5M$96.7M$-112.6M$-134.4M
YoY %+594.3%-54.9%-216.5%-19.3%
Net Margin62.2%36.1%-894.3%-384.0%
EPS (GAAP)$5.68$2.56-$3.15-$3.32
YoY %+297.2%-54.9%-223.0%-5.4%